| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.25 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |